Skip to content

Effects of Exercise on stationary bicycle in Hemodialysis Patients

Effects of intradialitic aerophonal exercise with partial restriction of blood flow in patients in hemodialysis: a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8t2p2m
Enrollment
Unknown
Registered
2017-10-26
Start date
2017-02-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney disease

Interventions

The physical exercise groups – Partial blood flow restriction training group (GRFS) and exercise without partial blood flow restriction group (GE) - undergo an exercise protocol composed of 20 minutes
Mesocycle 2 - Weeks 5 - 8: participants will pedal to a HR between 64% and 76% of the maximum HR, corresponding to 12-13 on the perceived exertion scale of 6 to 20 (BORG, 1982). An exercise session fo
2) with the patient standing, fitting the blood flow restriction accessory
3) with the patient sitting in the hemodialisy’s chair, pressurized band inflation for RFS
4) positioning of the ergometric bicycle in front of the patient
and 5) pedaling. The maximum HR determined from the following formula (NES et al., 2013): HRmax = 211 - (0.64x age). Patients who use HR-influencing medication, such as beta-blockers, will have their
Behavioural
G11.427.590.530.698.277

Sponsors

Escola Superior de Educação Física/Universidade Federal de Pelotas
Lead Sponsor
Universidade Católica de Pelotas
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with chronic kidney disease on hemodialysis; 18 years of age or over; both sexes.

Exclusion criteria

Exclusion criteria: With previous diagnosis of coronary artery disease; submitted to mechanical ventilation and hospitalized in the intensive care unit; with musculoskeletal limitation that impedes the performance of the exercise; with cognitive alterations that make it impossible to understand the instructions of the exercises; pregnant women; individuals with a history of deep venous thrombosis; with systolic blood pressure greater than or equal to 180 mmHg or greater diastolic equal to 105 mmHg at rest and resting heart rate greater than or equal to 120 bpm at rest; practitioners of any physical exercise program.

Design outcomes

Primary

MeasureTime frame
Inflammatory markers: interleukin-6 (IL-6), interleukin-10 (IL-10) and tumor necrosis factor (TNF), assessed by the ELISA method, at baseline (week 0) and at the end (week 12) of the study. It is expected to reduce levels of IL-6 and TNF and increase in IL-10 concentration among patients in the exercise groups exercise.;Oxidative stress markers: superoxide dismutase, glutathione peroxidase and catalase activity, assessed by enzymatic methods, at the beginning (week 0) and at the end (week 12) of the study. The levels of these enzymes are expected to increase among patients in the exercise groups.

Secondary

MeasureTime frame
Functional ability, assessed by the six-minute walk test at the beginning (week 0) and at the end (week 12) of the study. The distance traveled between patients belonging to the exercise groups is expected to increase.;Muscle strength, assessed by thoraco-lumbar dynamometry, at the beginning (week 0) and at the end (week 12) of the study. An increase in strength levels is expected among patients in the exercise groups.;Muscle thickness, assessed by ultrasound, at the beginning (week 0) and at the end (week 12) of the study. An increase in muscle thickness is expected among patients in the exercise groups.;Quality of life, assessed by the Kidney Disease Quality of Life Short Form - version 1.3 (KDQOL-SF) scores at the beginning (week 0) and at the end (week 12) of the study. It is expected to improve the quality of life of the patients belonging to the exercise groups.

Countries

Brazil

Contacts

Public ContactRodrigo Cardoso

Escola Superior de Educação Física/Universidade Federal de Pelotas

rodrigokohn21@yahoo.com.br+55(53)999114559

Outcome results

None listed

Source: REBEC (via WHO ICTRP)